ZenaDrone, a subsidiary of technology provider ZenaTech, has signed a memorandum of understanding with Rattler Medical to develop and manufacture a drone-based system for delivering temperature-controlled blood to military medical personnel on the battlefield.

Maintaining human blood within a safe temperature range from the supply point to the patient remains a central logistical challenge in combat medicine. To address this, the planned system combines ZenaDrone’s payload delivery capability with Rattler Medical’s temperature-controlled containers for transporting human blood. Under the proposed design, the container will be carried beneath a ZenaDrone aircraft and either released from the air or delivered on landing, where medical personnel would detach it.
ZenaTech, which specializes in AI-powered drones, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, views the agreement as an expansion of its defense work.
“Getting blood to a wounded service member quickly, and at the right temperature, is one of the most difficult logistics problems in combat medicine,” said Shaun Passley, Ph.D., CEO of ZenaTech. “This MOU pairs ZenaDrone’s cargo drone capability with a container system built by a team that has carried blood in the field. It also sets a defined path to a flying prototype and a demonstration with the U.S. military, extending our defense portfolio into battlefield medical logistics, applications we have long targeted for our drone platforms.”
Deploying drones for far-forward blood resupply is intended to overcome several operational limitations associated with conventional ground transport. Aircraft can bypass contested or damaged roads to reach medical teams faster while reducing the risk to personnel on resupply routes. Rather than concentrating supplies in a single conventional convoy, distributing blood across multiple drones helps ensure safe delivery if individual aircraft or trucks are lost. This approach also supports just-in-time delivery, allowing medical units to request blood as casualties occur instead of relying solely on pre-positioned stocks.
Rattler Medical brings direct operational insight to the joint effort, having been founded by U.S. Army combat medic veteran Donald Young alongside a team with established relationships across the military medical community.
“As a combat medic, I saw how much a casualty’s outcome can depend on how fast blood reaches the medic treating them,” said Mr. Young, Rattler Medical CEO. “Pairing our far-forward blood resupply capability with ZenaDrone’s aircraft gives medics a way to receive blood where ground transport cannot reach safely, and to receive it from many aircraft at once instead of a single vehicle. Our goal is to put this capability in front of military users next year.”
The two companies plan to build a flying prototype within the next two to three months and conduct testing to determine whether aerial release or landing delivery is the most effective deployment method. ZenaDrone is currently planning to demonstrate the system at a U.S. military facility in summer 2027, drawing on ZenaTech’s defense engagement activities and Rattler Medical’s military relationships. The initiative comes amid projected growth in the global medical drone delivery services market, which includes blood transfer and is expected by the Business Research Company to expand from US$510 million in 2026 to US$1.27 billion by 2030 at a compound annual growth rate of 25.5%.




